Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Innovations in Percutaneous Transluminal Coronary Angioplasty and TranscatheterAortic ValvesPublished:November 2011No.Of P...
Table Of ContentsAbout the authorDisclaimerEXECUTIVE SUMMARYOverview of percutaneous transluminal coronary angioplastyInno...
Implantation techniqueMarket opportunities in TAVsInnovations in TAVSapien valveCoreValve prosthesisOther investigational ...
About Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies...
Upcoming SlideShare
Loading in …5
×

Innovations in percutaneous transluminal coronary angioplasty and transcatheter aortic valves

783 views

Published on

Published in: Business, Health & Medicine
  • Be the first to comment

  • Be the first to like this

Innovations in percutaneous transluminal coronary angioplasty and transcatheter aortic valves

  1. 1. Innovations in Percutaneous Transluminal Coronary Angioplasty and TranscatheterAortic ValvesPublished:November 2011No.Of Pages:70Price:US $ 3835Report SummaryThis report covers innovations across the percutaneous transluminal coronary angioplasty andtranscatheter aortic valve spaces. Innovations in both devices and techniques are reviewed.Devices covered include drug eluting stents, drug coated balloons, embolic protection devicesand trascatheter valves. The report also examines the regulatory status of products underinvestigation.Features and benefits* Assess the markets for percutaneous transluminal coronary angioplasty devices andtranscatheter valves.* Forecast epidemiology of key cardiology indications which impact the PercutaneousTransluminal Coronary Angioplasty and transcatheter aortic valve markets.* Evaluate innovations in percutaneous transluminal coronary angioplasty devices.* Analyze how percutaneous transluminal coronary angioplasty techniques are changing.* Gain an understanding of the leading transcatheter aortic valves which are under investigationfor approval.HighlightsThe global market for percutaneous transluminal angioplasty is valued at $9.1bn in 2010, and isset to grow at a CAGR of 13.8% to reach $19.1bn in 2016. The market is being driven by the risein procedural volumes with an increase in the average age of the population in the US and Japan,and the increase in the penetration of PCI in Asia.Future directions in the DES space focus on inventing DES that are safer (lower risk ofthrombosis), more maneuverable in order to treat dispersed lesions, and have novel therapeuticproperties, such as self-expandable DES, bifurcation stents and DES with more than one drugoffering.New imaging techniques are the main area in transcatheter aortic valves innovation. EdwardsLifesciences Sapien valve became the first product to be approved in the US.
  2. 2. Table Of ContentsAbout the authorDisclaimerEXECUTIVE SUMMARYOverview of percutaneous transluminal coronary angioplastyInnovations in PTCA productsInnovations in PTCA techniquesInnovations in transcatheter aortic valvesOverview of percutaneous transluminal coronary angioplastySummaryIntroductionEpidemiology of cardiovascular diseasesIntroduction to PTCAPTCA procedureMarket size and forecasts for PTCAHistorical market size and forecastsInnovations in PTCA productsSummaryIntroductionInnovationsBalloon cathetersDrug-eluting stentsDrug-eluting balloonsEmbolic protection devicesVascular access closure devicesInnovations in PTCA techniquesSummaryIntroductionInnovationsIntravascular ultrasonographyCoronary physiologic assessmentHybrid coronary interventionAdjunct PTCA therapiesAnti-coagulants used in PTCAInnovations in transcatheter aortic valvesSummaryIntroductionEtiology of valve diseaseIntroduction to TAVI
  3. 3. Implantation techniqueMarket opportunities in TAVsInnovations in TAVSapien valveCoreValve prosthesisOther investigational devicesLeading trancatheter aortic valve manufacturersAppendixScopeMethodologyGlossary/AbbreviationsBibliography/ReferencesList Of TablesTable: Epidemiology of major cardiovascular diseases, 2010Table: Forecast epidemiology of dyslipidemia across the 7MM, 2010–16Table: Forecast epidemiology of stroke across the 7MM, 2010–16Table: Leading players in the global drug-coated balloon marketTable: Developmental stages of selected drug-coated balloon devicesTable: Standard derived IVUS measurementsTable: Leading TAV manufacturersTable: Leading TAV manufacturers (contd.)List Of FiguresFigure: Rotational atherectomy catheterFigure: Global Percutaneous Transluminal Coronary Angioplasty Market ($bn), 2010–16Figure: Potential market size for various applications of DCBs in the US, 2012Figure: Proximal occlusion deviceFigure: Fibernet device mounted on a guidewireFigure: Fibernet filter in the arterial vessel wallFigure: Vascular access closure deviceFigure: Normal coronary artery structure on IVUSFigure: Fractional flow reserve measurement using Intracoronary physiologic assessmentFigure: Ishimaru classification of the thoracic aortic landing zonesFigure: Normal aortic valve vs. bicuspid aortic valveFigure: Mechanical valveFigure: Tissue valveFigure: Transcatheter heart valveFigure: Transfemoral aortic valve implantationFigure: Transapical aortic valve implantation
  4. 4. About Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit our Market Research Blog

×